Skip to main content

macrogenics-logo

Rockville-based MacroGenics Inc. has struck a drug development deal with Gilead Sciences Inc. that could ultimately be worth $1 billion.

The licensing agreement is for the development and potential commercialization for drugs directed at up to four undisclosed targets.

{iframe}http://www.bizjournals.com/washington/news/2013/01/07/macrogenics-could-get-1b-payday.html?ana=e_du_pap&s=article_du&ed=2013-01-07{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.